SIREN : 801123688
LE GRENIER MEDOCAIN is a French company founded 12 years ago, specialized in the sector Gestion de fonds. Based in BLANQUEFORT (33290), this company of category PME shows in 2019 a revenue of 83 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 83 119 € | 77 402 € | 94 208 € | 120 738 € |
| Net income | 49 642 € | 150 445 € | 494 910 € | 1 947 € | 2 543 € | 909 € | -1 127 € |
| EBITDA | N/C | N/C | N/C | -445 € | -371 € | 721 € | 1 520 € |
| Net margin | N/C | N/C | N/C | 2.3% | 3.3% | 1.0% | -0.9% |
In 2022, LE GRENIER MEDOCAIN generates positive net income of 50 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
49 642 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.126%
93.127%
62.7%
In 2022, the debt ratio of LE GRENIER MEDOCAIN (0.13) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2022, the financial autonomy of LE GRENIER MEDOCAIN (93.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 1861.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
1861.176
In 2022, the liquidity ratio of LE GRENIER MEDOCAIN (1861.18) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 109 transactions of similar company sales in 2022, the value of LE GRENIER MEDOCAIN is estimated at 286 317 € (range 134 314€ - 627 578€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 109 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LE GRENIER MEDOCAIN with other companies in the same sector:
The revenue of LE GRENIER MEDOCAIN in 2019 is 83 k€.
Yes, LE GRENIER MEDOCAIN generated a net profit of 50 k€ in 2022.
The headquarters of LE GRENIER MEDOCAIN is located in BLANQUEFORT (33290), in the department Gironde.
The tax return of LE GRENIER MEDOCAIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LE GRENIER MEDOCAIN operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.